Spacelabs Healthcare to Present New Patient Monitoring Solutions at CACCN’s Dynamics 2012 Conference in Vancouver, BC

ISSAQUAH, Wash.--(BUSINESS WIRE)--Spacelabs Healthcare will present new patient monitoring solutions, including the AriaTele^TM telemetry transmitter* and qube^TM compact patient monitor as well as the recently released XPREZZON^TM bedside monitor at this year’s annual meeting of the Canadian Association of Critical Care Nurses, taking place this week in Vancouver, British Columbia.

“Our new high performance solutions symbolize design excellence – tools to enhance the quality of patient care and improve outcomes, but which also have aesthetic appeal to caregivers and their patients”

Spacelabs will also demonstrate ICS XPREZZ^TM, the latest of Spacelabs’ renowned ICS G2 connectivity solutions, which takes mobility of care to a higher level by providing caregivers with comprehensive patient information — including near-live waveforms and graphical trends — on their iPads or other mobile devices.

“Our new high performance solutions symbolize design excellence – tools to enhance the quality of patient care and improve outcomes, but which also have aesthetic appeal to caregivers and their patients,” said Nicholas Ong, President of Spacelabs Healthcare.

*The AriaTele telemetry transmitter is Pending Health Canada License – Not for Sale.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s products. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.